Review article: next generation diagnostic modalities in gastroenterology – gas phase volatile compound biomarker detection
- 20 February 2014
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 39 (8), 780-789
- https://doi.org/10.1111/apt.12657
Abstract
The detection of airborne gas phase biomarkers that emanate from biological samples like urine, breath and faeces may herald a new age of non-invasive diagnostics. These biomarkers may reflect status in health and disease and can be detected by humans and other animals, to some extent, but far more consistently with instruments. The continued advancement in micro and nanotechnology has produced a range of compact and sophisticated gas analysis sensors and sensor systems, focussed primarily towards environmental and security applications. These instruments are now increasingly adapted for use in clinical testing and with the discovery of new gas volatile compound biomarkers, lead naturally to a new era of non-invasive diagnostics. To review current sensor instruments like the electronic nose (e-nose) and ion mobility spectroscopy (IMS), existing technology like gas chromatography-mass spectroscopy (GC-MS) and their application in the detection of gas phase volatile compound biomarkers in medicine - focussing on gastroenterology. A systematic search on Medline and Pubmed databases was performed to identify articles relevant to gas and volatile organic compounds. E-nose and IMS instruments achieve sensitivities and specificities ranging from 75 to 92% in differentiating between inflammatory bowel disease, bile acid diarrhoea and colon cancer from controls. For pulmonary disease, the sensitivities and specificities exceed 90% in differentiating between pulmonary malignancy, pneumonia and obstructive airways disease. These sensitivity levels also hold true for diabetes (92%) and bladder cancer (90%) when GC-MS is combined with an e-nose. The accurate reproducible sensing of volatile organic compounds (VOCs) using portable near-patient devices is a goal within reach for today's clinicians.Keywords
This publication has 81 references indexed in Scilit:
- Electronic Nose Technology for Detection of Invasive Pulmonary Aspergillosis in Prolonged Chemotherapy-Induced Neutropenia: a Proof-of-Principle StudyJournal of Clinical Microbiology, 2013
- Point-of-care breath test for biomarkers of active pulmonary tuberculosisTuberculosis, 2012
- Colorectal cancer screening with odour material by canine scent detectionGut, 2011
- Different Fecal Microbiotas and Volatile Organic Compounds in Treated and Untreated Children with Celiac DiseaseApplied and Environmental Microbiology, 2009
- Prospects for Clinical Application of Electronic-Nose Technology to Early Detection ofMycobacterium tuberculosisin Culture and SputumJournal of Clinical Microbiology, 2006
- Detection of Lung Cancer by Sensor Array Analyses of Exhaled BreathAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Selected ion flow tube mass spectrometry (SIFT‐MS) for on‐line trace gas analysisMass Spectrometry Reviews, 2004
- Diagnostic potential of breath analysis—focus on volatile organic compoundsClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- A novel multigene family may encode odorant receptors: A molecular basis for odor recognitionCell, 1991
- Quantitative Analysis of Urine Vapor and Breath by Gas-Liquid Partition ChromatographyProceedings of the National Academy of Sciences, 1971